Cefotetan-induced	cefotetan-induced	O	O	O	O
immune	immune	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Immune	immune	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
drug-adsorption	drug-adsorption	O	O	O	O
mechanism	mechanism	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
described	described	O	O	O	O
primarily	primarily	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
penicillins	penicillins	O	O	OTHERS	I
and	and	O	O	O	O
first-generation	first-generation	O	O	O	O
cephalosporins	cephalosporins	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
describe	describe	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
anemia	anemia	O	DISEASE	OTHERS	I
while	while	O	O	O	O
receiving	receiving	O	O	O	O
intravenous	intravenous	O	O	O	O
cefotetan	cefotetan	O	O	OTHERS	I
.	.	O	O	O	O

Cefotetan-dependent	cefotetan-dependent	O	O	O	O
antibodies	antibodies	O	O	O	O
were	were	O	O	O	O
detected	detected	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
's	's	O	O	O	O
serum	serum	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
an	an	O	O	O	O
eluate	eluate	O	O	O	O
prepared	prepared	O	O	O	O
from	from	O	O	O	O
his	his	O	O	O	O
red	red	O	O	O	O
blood	blood	O	O	O	O
cells	cells	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
eluate	eluate	O	O	O	O
also	also	O	O	O	O
reacted	reacted	O	O	O	O
weakly	weakly	O	O	O	O
with	with	O	O	O	O
red	red	O	O	O	O
blood	blood	O	O	O	O
cells	cells	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
absence	absence	O	O	O	O
of	of	O	O	O	O
cefotetan	cefotetan	O	O	OTHERS	I
,	,	O	O	O	O
suggesting	suggesting	O	O	O	O
the	the	O	O	O	O
concomitant	concomitant	O	O	O	O
formation	formation	O	O	O	O
of	of	O	O	O	O
warm-reactive	warm-reactive	O	O	O	O
autoantibodies	autoantibodies	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
observations	observations	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
conjunction	conjunction	O	O	O	O
with	with	O	O	O	O
clinical	clinical	O	O	O	O
and	and	O	O	O	O
laboratory	laboratory	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
extravascular	extravascular	O	O	O	O
hemolysis	hemolysis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
are	are	O	O	O	O
consistent	consistent	O	O	O	O
with	with	O	O	O	O
drug-induced	drug-induced	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
possibly	possibly	O	O	O	O
involving	involving	O	O	O	O
both	both	O	O	O	O
drug-adsorption	drug-adsorption	O	O	O	O
and	and	O	O	O	O
autoantibody	autoantibody	O	O	O	O
formation	formation	O	O	O	O
mechanisms	mechanisms	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
case	case	O	O	O	O
emphasizes	emphasizes	O	O	O	O
the	the	O	O	O	O
need	need	O	O	O	O
for	for	O	O	O	O
increased	increased	O	O	O	O
awareness	awareness	O	O	O	O
of	of	O	O	O	O
hemolytic	hemolytic	O	O	OTHERS	I
reactions	reactions	O	O	O	O
to	to	O	O	O	O
all	all	O	O	O	O
cephalosporins	cephalosporins	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

